GE HealthCare Technologies Inc. $GEHC Shares Sold by MassMutual Private Wealth & Trust FSB

MassMutual Private Wealth & Trust FSB lowered its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 13.7% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 2,508 shares of the company’s stock after selling 398 shares during the period. MassMutual Private Wealth & Trust FSB’s holdings in GE HealthCare Technologies were worth $186,000 at the end of the most recent reporting period.

A number of other institutional investors have also modified their holdings of the stock. N.E.W. Advisory Services LLC acquired a new position in GE HealthCare Technologies during the first quarter worth $25,000. Bogart Wealth LLC grew its holdings in GE HealthCare Technologies by 260.0% during the first quarter. Bogart Wealth LLC now owns 342 shares of the company’s stock worth $28,000 after acquiring an additional 247 shares during the period. Stonebridge Financial Group LLC grew its holdings in GE HealthCare Technologies by 165.7% during the first quarter. Stonebridge Financial Group LLC now owns 356 shares of the company’s stock worth $29,000 after acquiring an additional 222 shares during the period. Ameriflex Group Inc. acquired a new position in GE HealthCare Technologies during the fourth quarter worth $31,000. Finally, Olde Wealth Management LLC acquired a new position in GE HealthCare Technologies during the first quarter worth $35,000. Institutional investors and hedge funds own 82.06% of the company’s stock.

GE HealthCare Technologies Price Performance

Shares of NASDAQ GEHC opened at $74.00 on Friday. GE HealthCare Technologies Inc. has a fifty-two week low of $57.65 and a fifty-two week high of $94.80. The business has a 50 day moving average price of $74.54 and a two-hundred day moving average price of $73.33. The company has a quick ratio of 0.93, a current ratio of 1.16 and a debt-to-equity ratio of 0.85. The firm has a market cap of $33.79 billion, a PE ratio of 15.16, a price-to-earnings-growth ratio of 2.93 and a beta of 1.13.

GE HealthCare Technologies (NASDAQ:GEHC) last released its earnings results on Wednesday, July 30th. The company reported $1.06 EPS for the quarter, topping analysts’ consensus estimates of $0.91 by $0.15. GE HealthCare Technologies had a return on equity of 23.93% and a net margin of 11.22%.The company had revenue of $5 billion for the quarter, compared to the consensus estimate of $4.96 billion. During the same quarter last year, the business posted $1.00 EPS. GE HealthCare Technologies’s quarterly revenue was up 3.5% compared to the same quarter last year. GE HealthCare Technologies has set its FY 2025 guidance at 4.430-4.630 EPS. Sell-side analysts expect that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, August 15th. Shareholders of record on Friday, July 25th were issued a dividend of $0.035 per share. This represents a $0.14 dividend on an annualized basis and a yield of 0.2%. The ex-dividend date of this dividend was Friday, July 25th. GE HealthCare Technologies’s dividend payout ratio (DPR) is currently 2.87%.

Analysts Set New Price Targets

A number of brokerages recently weighed in on GEHC. Morgan Stanley dropped their price objective on GE HealthCare Technologies from $78.00 to $74.00 and set an “equal weight” rating on the stock in a report on Thursday, July 31st. Citigroup upped their price objective on GE HealthCare Technologies from $89.00 to $93.00 and gave the stock a “buy” rating in a report on Thursday, July 31st. Zacks Research raised GE HealthCare Technologies from a “hold” rating to a “strong-buy” rating in a report on Thursday, August 28th. BTIG Research reaffirmed a “buy” rating on shares of GE HealthCare Technologies in a report on Monday, July 14th. Finally, Wall Street Zen upgraded GE HealthCare Technologies from a “hold” rating to a “buy” rating in a research report on Saturday, May 31st. One investment analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and two have given a Hold rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $88.40.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.